Target intelligence / Profile preview

Primary and secondary amines

Molecular classification
Chemical functional group, Small molecule class
01

Overview

Primary and secondary amines are chemical functional groups characterized by a nitrogen atom bonded to one or two alkyl or aryl groups, respectively [1]. In a biological context, these are not singular therapeutic targets (like a specific protein or receptor) but are instead essential chemical motifs found in endogenous signaling molecules, including neurotransmitters like dopamine, serotonin, and histamine [2]. They play a pivotal role in pharmacology because the basicity of the amine group allows for protonation at physiological pH, enabling high-affinity ionic bonding to specific biological targets such as G protein-coupled receptors (GPCRs) and transporters [3]. These groups are also the primary substrates for metabolic enzymes like monoamine oxidases (MAO-A and MAO-B) and cytochrome P450 enzymes, which modulate the biological half-life of both natural and synthetic compounds [4]. In medicinal chemistry, the modification of primary and secondary amines is a core strategy to optimize a drug's pharmacokinetics, solubility, and blood-brain barrier permeability [5]. Because the term refers to a broad class of chemical functional groups rather than a specific macromolecular target, it is considered an incorrect designation for a single therapeutic target entity.

Other names
R-NH2 (Primary amines)R2-NH (Secondary amines)Biogenic aminesAmino groups
02

Mechanism of action

Primary and secondary amines act as substrates for metabolic enzymes such as monoamine oxidases (MAO) and are critical functional groups in ligands that bind to G protein-coupled receptors (GPCRs) via ionic interactions with conserved aspartate residues.

03

Biological functions

NeurotransmissionMetabolismEnzymatic substratepH regulationCell signaling
04

Disease associations

Neurological disordersMetabolic disordersHypertension
05

Safety considerations

Metabolic instabilityPotential for N-nitrosation (carcinogenicity)Off-target binding to hERG channelsDrug-drug interactions via MAO inhibition
06

Interacting drugs

Monoamine oxidase inhibitors (MAOIs)

4 more in the full profile.

07

Biomarkers

Urinary biogenic aminesPlasma catecholaminesVanillylmandelic acid (VMA)

Beyond the preview

Go deeper on Primary and secondary amines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primary and secondary amines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call